ebook Munafa Stock Market Course + Intraday & FNO calls  

       

Hoth Therapeutics (HOTH) Technical (Analysis) Reports Hoth Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Hoth Therapeutics (HOTH)

Technical Analysis Report for USA stock HOTH Hoth Therapeutics. Dated: 12 Dec 2025 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange

If you are looking for Tomorrow's Movement Predictions for USA stock HOTH Hoth Therapeutics then click here. or read Experts views on Hoth Therapeutics or Forecast & share price targets of Hoth Therapeutics

Hoth Therapeutics Opened at 1.20 and Closed at: 1.17, which is -3.42% of previous session's close. It moved within a range of 1.16 and 1.22
The session was a Bearish session with an average volume of 72200, which is -22.44% of previous session's volumes.

  • The stock has fallen, and its mid term trend is also negative and in a downtrend.

A Golden cross was found 4 days back on short term averages

A Dead cross was found 8 days back on long term averages

Support for tomorrow is 1.14 and resistance for tomorrow is 1.2
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 1.15, 1.12 resistance for tomorrow's hourly charts is 1.21, 1.24

10 Day SMA for Hoth Therapeutics (HOTH) is 1.18 and stock is trading below these levels. This is not a good sign for its short term trend

20 Day SMA for Hoth Therapeutics (HOTH) is 1.17 and the stock is trading above these levels. This is a good sign for its mid term trend

50 Day SMA for Hoth Therapeutics (HOTH) is 1.31 and the stock is trading below these levels. This is not a good sign for its mid to long term trend

100 Day SMA is 1.38 and the stock is trading below these levels. This is not a good sign for its long term trend

200 Day SMA Hoth Therapeutics is 1.21 and stock is trading below these levels. This is not a good sign for its long term trend

20 DMA of Hoth Therapeutics is at 1.17 and 200 DMA is at 1.21, while 50 DMA and 100 DMA are at 1.31 and 1.38 respectively

Hoth Therapeutics (HOTH) moving average of 20 SMA is at 1.17 and 20 EMA is at 1.21

Hoth Therapeutics (HOTH) moving average of 50 SMA is at 1.31 and 50 EMA is at 1.29

Hoth Therapeutics (HOTH) moving average of 100 SMA is at 1.38 and 100 EMA is at 1.33

Hoth Therapeutics (HOTH) moving average of 200 SMA is at 1.21 and 200 EMA is at 1.14

Nu Skin has performed better than Hoth Therapeutics in short term. You could have earned much better returns by investing in Nu Skin, about 11.97% more returns!

Xencor Inc has performed better than Hoth Therapeutics in short term. You could have earned much better returns by investing in Xencor Inc, about 12.33% more returns!

Vistagen Therapeutics has performed better than Hoth Therapeutics in short term. You could have earned much better returns by investing in Vistagen Therapeutics, about 13.52% more returns!

Hoth Therapeutics has performed better than Veru Inc in short term. Holding Hoth Therapeutics could be a better choice for now!

Hoth Therapeutics has performed better than Prophase Labs in short term. Holding Hoth Therapeutics could be a better choice for now!

Puma Biotechnology has performed better than Hoth Therapeutics in short term. You could have earned much better returns by investing in Puma Biotechnology, about 21.52% more returns!

Ovid Therapeutics has performed better than Hoth Therapeutics in short term. You could have earned much better returns by investing in Ovid Therapeutics, about 26.87% more returns!

Hoth Therapeutics has performed better than Medpace Holdings in short term. Holding Hoth Therapeutics could be a better choice for now!

Karyopharm Therapeutics has performed better than Hoth Therapeutics in short term. You could have earned much better returns by investing in Karyopharm Therapeutics, about 24.04% more returns!

Orthopediatrics Corp has performed better than Hoth Therapeutics in short term. You could have earned much better returns by investing in Orthopediatrics Corp, about 7.01% more returns!

Irhythm Technologies has performed better than Hoth Therapeutics in short term. You could have earned much better returns by investing in Irhythm Technologies, about 0.52% more returns!

Corcept Therapeutics has performed better than Hoth Therapeutics in short term. You could have earned much better returns by investing in Corcept Therapeutics, about 18.16% more returns!

Biogen Inc has performed better than Hoth Therapeutics in short term. You could have earned much better returns by investing in Biogen Inc, about 5.59% more returns!

Aytu Bioscience has performed better than Hoth Therapeutics in short term. You could have earned much better returns by investing in Aytu Bioscience, about 11.73% more returns!

Aurinia Pharmaceuticals has performed better than Hoth Therapeutics in short term. You could have earned much better returns by investing in Aurinia Pharmaceuticals, about 4.94% more returns!

Hoth Therapeutics has performed better than Amphastar Pharmaceuticals in short term. Holding Hoth Therapeutics could be a better choice for now!

Hoth Therapeutics has performed better than Agios Pharmaceuticals in short term. Holding Hoth Therapeutics could be a better choice for now!

Hoth Therapeutics Technical analysis of indicators

Price action analysis of Hoth Therapeutics (HOTH) based on a short term time period is neutral. A longer time frame might give a better analysis.

ADX buy sell signal for Hoth Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.

MACD generated a BUY signal for Hoth Therapeutics in short term but the buy signal is initial and weak.

Hoth Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.

Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down

CCI has generated a SELL signal for Hoth Therapeutics in short term and SELL signal is strong!

RSI is generating a SELL signal in short term but selling is losing momentum.

MRSI is in positive zone. This is a BUY zone

Stock of Hoth Therapeutics is picking up buying momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 1.19 and Hoth Therapeutics HOTH stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down

People seem to be coming out and selling the Hoth Therapeutics HOTH stock. Volume based technical analysis of Hoth Therapeutics HOTH stock is negative.

Hoth Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for USA stock HOTH Hoth Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And HOTH Experts View which covers a lot of information including buying and selling signals

HOTH future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Hoth Therapeutics or View Candle Stick Charts here

Chart Hoth Therapeutics (HOTH)  Technical (Analysis) Reports Hoth Therapeutics [

Videos related to: Hoth Therapeutics (HOTH) Technical (Analysis) Reports Hoth Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com

Hindi Basics How To Trade In FnO Futures Options Stock Market

Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You

Hoth Therapeutics (HOTH)  Technical (Analysis) Reports Hoth Therapeutics [

 

Back to top